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of our patients and found MIS in only 
the 2 patients reported in our article.' 
Neither patient had evidence of myocar- 
dial ischemia in proximity to use of the 
bilevel PAP system; in fact, their prob- 
lems occurred days after use of the sys- 
tem. 
In reference to the Hipona study, the 
preliminary data may reflect a rapid in- 
crease in myocardial perfusion, rather 
than an increase in myocardial ischemia. 
In CHF, the blood flow to the distended 
left ventricular (LV) wall is compro- 
mised. LV wall tensions are elevated as 
the result of increased peripheral vascu- 
lar resistance, decreased (CO), and a dis- 
tended end-diastolic volume. As Hipona 
et al. note, the introduction of the 
bilevel PAP system creates an increase 
in airway pressure and an increase in in- 
trathoracic pressure. This increase in in- 
trathoracic pressure is transmitted to all 
intrathoracic structures, including the 
left ventricle. This additional pressure 
around the ventricles assists in LV emp- 
tying and the movement of blood into 
the extrathoracic aorta.' This effect pro- 
duces a reduction in LV wall tension 
while increasing the CO. The net result 
of this effect is exactly what Hipona et 
al. suggest, a reduction in LV end-dia- 
stolic volume. The decrease in LV end- 
diastolic volume and wall tension may 
produce a rapid increase in LV myocar- 
dial blood flow. A sudden return of 
blood to compromised areas of the LV 
wall should produce a washout of myo- 
cardial proteins, including CK-MB iso- 
enzymes, which may have leaked from 
ischemic myocytes. Dramatic reversal of 
pulmonary edema symptoms have been 
observed within seconds of institution of 
the bilevel PAP system, indicating the 
extremely rapid onset of these cardio- 
vascular effects. 
Measurement of cardiac enzymes 
following such a washout would likely 
demonstrate a transient positive peak. 
Treatments that do not produce such a 
rapid resolution of CHF produce a 
slower resumption of LV blood flow and, 
hence, a Lower, broader pattern of en- 
zyme leakage. If MI is defined only by 
the height of a CK or CK-MB value, 
then the bilevel PAP system might ap- 
pear to produce an MI in some patients 
for whom other treatment modalities 
would not. 
The clinical data reported for these 
patients seem to support this explana- 
tion. In both Dr. Hipona et al.'s study 
and our own, the patients' CHFs im- 
proved dramatically and endotracheal in- 
tubation was averted. If the bilevel PAP 
system were in fact increasing myocar- 
dial ischemia, these patients' CHFs 
would be expected to worsen rather than 
improve. It is unlikely that a treatment 
that increased myocardial cell death 
would produce an improvement in CO. 
Other indicators of myocardial ischemia 
such as ECG findings, complaints of 
chest pain, or subjective deterioration 
also should be present in the bilevel PAP 
system group if it truly produced myo- 
cardial ischemia. 
In terms of the pressures used in the 
noninvasive pressure support systems, 
we now routinely use inspiratory posi- 
tive airway pressures (IPAPs) of 14- 18 
cm H 2 0  with expiratory positive airway 
pressures (EPAPs) of 10- 15 cm H 2 0  for 
our CHF patients. Anecdotal reports 
from other clinicians using these systems 
note that EPAPs or CPAPs of 15-20 cm 
H20 are well tolerated in these patients. 
In conclusion, our continued clinical 
experience with this system has con- 
vinced us of its efficacy and safety. We 
have experienced no problem in using 
this device in the face of coronary artery 
disease and have begun releasing care- 
fully defined patient groups from the ED 
following bilevel PAP system treatment 
for CHF. We do not believe that isolated 
elevations in CK-MB levels in the face 
of improvement in all other clinical pa- 
rameters is indicative of bilevel PAP 
system-induced MI. Isolated CK-MB 
elevations most likely represent a wash- 
out effect associated with a rapid change 
in global myocardial perfusion. Based on 
experience to date. we believe that bi- 
level ventilation remains a first-line ther- 
apy for the management of acute cardio- 
genic CHF. 
ALFRED D. SACCHE~TI. MD 
RUSSELL H. HARRIS, MD 
Our Lady of Lourdes Medical Center, 
Camden, NJ 
Department of Emergency Medicine 
(ADS, RHH) 
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Arterial and Peripheral 
Venous Lactate Levels 
To the Ediror-Elevated arterial lac- 
tate level is a sensitive and valuable 
marker of systemic hypoperfusion.'.' 
With both diagnostic and prognostic util- 
ity in patients in circulatory shock, the 
arterial lactate concentration is a periph- 
erally retrievable sample of the weighted 
sum of all sources of lactate production 
and use within a patient. As such, the 
peripheral arterial lactate value tradition- 
ally has been considered the standard for 
lactate determination. Peripheral venous 
samples, it has been argued, may be in- 
ordinately influenced by changes in local 
perfusion. Specifically, venous samples 
might be falsely elevated when with- 
drawn from a peripheral vein, particu- 
larly from a limb to which a tourniquet 
has been applied. 
The need to sample arterial blood is 
disadvantageous in that greater technical 
skill is required for acquisition, arterial 
access is difficult in hypotensive pa- 
tients, there is a risk of threatening distal 
blood flow (particularly in the hand), and 
the supply cost is greater than it is for 
venous sampling. If peripheral venous 
lactate levels were demonstrated to be as 
reliable as arterial levels, a technically 
easier, safer, and more cost-effective 
means of screening selected patients for 
this important marker of serious disease 
would be available. We studied the re- 
lationship between arterial and periph- 
eral venous lactate concentrations in ED 
-~ 
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patients, determining the correlation be- 
tween these values and examining the 
sensitivity and specificity of abnormal 
venous levels as a screen for arterial hy- 
perlactacidemia. 
Methods 
Study Design. This was prospec- 
tive, cross-sectional study of a conven- 
ience sample of adult ED patients for 
comparison of arterial and venous lactate 
levels. 
Setting and Population. Patients 
were enrolled at one urban, university 
hospital ED (annual census -70,000 vis- 
its) between November and December 
1992. Any medical, surgical, or trauma 
patient whose clinical evaluation in- 
cluded both arterial and venous blood 
samplings was included. Given the ob- 
servational nature of this study, the in- 
stitutional review committee of our in- 
stitution waived the need for patient 
consent. 
Measurements. Radial arterial punc- 
ture was the preferred method for arterial 
sampling. Choice of venipuncture site 
was left to the nurse or physician per- 
forming the procedure, as was the deci- 
sion to use a tourniquet. Patients were 
excluded from the study if the time be- 
tween arterial and venous samplings was 
>20 minutes. No sample, arterial or ve- 
nous, was drawn proximal to an ische- 
mic limb. Patients in cardiopulmonary 
arrest were excluded. 
All samples were placed in an ice 
water bath prior to processing. Lactate 
concentration was measured with a lac- 
timeter (YSI Model 2300 Stat Lactime- 
ter, Yellow Springs, OH) that was main- 
tained in the ED. Analyses were 
performed by respiratory therapists 
trained in using, maintaining, and cali- 
brating the instrument. 
Data Analysis. Statistical analyses 
were performed with JMP software 
(SAS Institute, Cary, NC). The sensitiv- 
ity and specificity of abnormal venous 
levels in predicting elevated arterial lev- 
els were calculated. The relationship be- 
tween venous and arterial levels was ex- 
amined first with least-squares linear 
regression, then with bias and precision 
plotting as described by Altman and 
Bland,3 with a 95% CI calculated for the 
bias between venous and arterial levels. 
All results are reported as a mean -C SD. 
I TABLE 1 Diagnoses of Patients with Elevated Serum Lactate Levels ............................................................................... .............. ... 
Diagnosis 
Venous Lactate Arterial Lactate 
(mmolk) (mmofi) 
Pulmonary edema 
Congestive heart failure 
Acute-on-chronic renal failure 
Diabetic ketoacidosis 




Ruptured abdominal aorta 
Blunt abdominal trauma 
Hip fracture 
Gunshot wound to the leg 
Cocaine intoxication 
5 .4  
2 .0  
3.4  
























Of the 48 patients studied, the mean 
age was 56 -t 20 years (range 17-83 
years). The mean time between arterial 
and venous samplings (with arterial typ- 
ically being done first) was 6.0 2 5.5 
minutes. Thirteen individuals had abnor- 
mal arterial levels (i.e., 21.6 mmoVL, 
Table 1). Peripheral venous lactate 
proved to be an effective marker for an 
elevated arterial lactate level; an abnor- 
mally elevated peripheral venous level 
was 100% (95% CI 90% to 100%) sen- 
sitive and 86% (95% CI 76% to 96%) 
specific in detecting arterial hyperlact- 
acidemia. A strong correlation between 
arterial and venous levels was found 
(rz = 0.71, p c 0.001, Fig. 1). In general, 
venous levels tended to be higher than 
arterial levels in any patient, with the 
mean difference (arterial level - venous 
level) being -0.18 mmoVL (95% CI 
-0.372 to 0.012). Greater spread be- 
tween arterial and venous levels was 
noted at higher lactate concentrations 
(Fig. 2). No significant relationship ex- 
isted between the time between arterial 
and venous samplings and the difference 
between arterial and venous levels. 
Discussion 
Circulatory shock is currently rec- 
ognized to be a perfusion deficit during 
which systemic O2 delivery is inadequate 
to meet systemic O2 demands4 In the in- 
tensive care unit (ICU) setting, sophis- 
ticated cardiopulmonary monitoring can 
be used to detect subtle changes in tissue 
perfusion. Unfortunately, in the ED, few 
of these modalities are practical for rap- 
idly assessing patient hemodynamic 
status. While many patients present in 
overt hemodynamic shock, others may 
rally adequate compensatory mecha- 
nisms t o  such an extent that their degree 
of illness is ~nderestimated.~ The mea- 
surement of lactate levels is one readily 
available laboratory adjunct that may 
alert the clinician to the presence of un- 
suspected systemic hypoperfusion, and 
potentially impact the treatment of these 
critically ill patients.6 
Lactic acidosis was first associated 
with hypoperfusion by Clausen in 1925, 
who noted elevated lactate levels in chil- 
dren in hypovolemic shock.' Broder and 
Weil in 1964 demonstrated that elevated 
lactate levels held significant prognostic 
import: Only 11% of the patients in cir- 
culatory shock with lactate values >4 
mmol/L survived their illnesses.' The 
prognostic value of hyperlactacidemia 
subsequently has been confirmed in sev- 
eral other studies.*- lo Recently, several 
investigators have examined the utility 
of lactate levels as a guide to therapy in 
specific disease processes. Rutherford 
and coworkers found the degree of base 
deficit (a reflection of lactic acidosis) to 
be an independent predictor of mortality 
in a regression model that included tra- 
ditional clinical parameters as well as the 
revised trauma score and TRISS scor- 
ing." In 1994, a study by Abramson and 
associates found that in young trauma 
victims, the rate of lactate clearance was 
highly prognostic, with 100% survival 
among the patients who cleared their lac- 
tic acidosis within 24 hours and only 
13% survival among those who had not 
corrected the abnormality within 48 
hours. '' 
Traditionally, arterial samples have 
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I FIGURE 1. Correlation between arterial and venous lactate concentrations (r2 = 0.71, p < 0.001). 
been desired for lactate sampling. Arte- 
rial samples represent a completely 
mixed sample of all sites of lactate pro- 
duction and consumption. Peripheral ve- 
nous samples have been considered the 
least desirable for lactate sampling. It 
has been assumed that phlebotomy tech- 
nique (particularly tourniquet applica- 
tion) can result in falsely elevated levels. 
Surprisingly, the only study found to 
support this claim examined peripheral 
venous lactate levels in extremities sub- 
jected to Bier block anesthesia (exsan- 
guination with an Esmarch bandage fol- 
lowed by tourniquet application 100 mm 
Hg over systolic blood pressure for r20 
minutes).13 Without such extreme local 
ischemia, it is likely that the hyperlact- 
acidemia seen in critically ill patients is 
due largely to splanchnic and not re- 
gional musculoskeletal hypoperfusion. 
Adams and Hazard compared ante- 
cubital venous with arterial lactate sam- 
plings in ICU patients and concluded 
that peripheral venous lactate correlated 
highly to arterial levels in this popula- 
tion, demonstrating an r' value of 0.99.14 
Unlike the present study, these authors 
studied patients in whom resuscitation 
was largely under way. This was not true 
in our patient population; the bias and 
less rigorous correlation seen in our 
study may in part be due to more pro- 
found perfusion deficits in our patients. 
This possibility is especially interesting 
for those individuals in whom levels 
were very high. The bias-precision plot 
shown in Figure 2 suggests that in most 
of the patients, the arterial lactate was 
about 0.18 mmol/L lower than the ve- 
nous. There also was evidence of greater 
arterial-venous disparity at higher lac- 
tate concentrations. Even in the patients 
with the highest lactate concentrations, 
the arterial-venous discrepancy was rel- 
atively small, and probably of little clin- 
ical import. 
Limitations and Future Questions 
The hectic pace of the ED setting re- 
quired certain concessions in study de- 
sign to accomplish our investigation. Ar- 
terial and venous samples could rarely 
be drawn simultaneously. Control over 
the choice of venous site and the dura- 
tion of tourniquet use was not possible. 
Although we studied 48 patients, 
only 13 of these had elevated lactate lev- 
els. The limited number of upper-range 
values prevents a fully confident corre- 
lation analysis. Although some disagree- 
ment may occur between arterial and ve- 
nous concentrations in more profound 
lactic acidosis, there was no instance of 
a venous lactate level that would have 
been clinically misleading. Furthermore, 
the heterogeneity of our ill population 
precludes drawing specific conclusions 
within any disease subset. 
We allowed a maximum of 20 
minutes between arterial and venous 
sticks. The clearance of lactate following 
resuscitation in critically ill or injured 
patients is prolonged (with typical half- 
lives of 18 While we would an- 
ticipate that brief periods of intervening 
resuscitation between sampling should 
not alter results substantially, our study 
design provides no means of determin- 
ing the impact of early resuscitative 
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measures (airway control, vascular ac- 
cess, and hemodynamic support) on our 
results. 
We did not use other measures to de- 
termine the association of peripheral ve- 
nous lactic acidosis with independent 
measures of perfusion (i.e., other than 
peripheral arterial lactate levels). Sys- 
temic lactic acidosis may be due to  a va- 
riety of causes (e.g., anaerobic muscle 
use or metabolic disorders) other than 
hypoperfusion. Nonetheless, the persis- 
tence of systemic lactic acidosis despite 
adequate perfusion would provide valu- 
able clinical information. 
Irrespective of the above limitations, 
our data suggest that these uncontrolled 
variables have only minimal impact on 
the relationship between arterial and pe- 
ripheral venous samples. The technique 
used in our study closely parallels the 
typical ED routine in which timing of 
blood draws, initiation of resuscitation, 
and use of tourniquets are largely uncon- 
trolled phenomena. 
Conclusion 
Peripheral venous lactate measure- 
ment appears to be a useful, minimally 
invasive clinical tool for evaluating pa- 
tients for the presence of occult tissue 
hypoperfusion. Our data suggest that pe- 
ripheral venous sampling is a reliable al- 
ternative to arterial sampling in making 
the diagnosis of hyperlactacidemia in 
ED patients. 
JOHN G. YOUNGER, MD 
JAY L. FALK, MD 
STEVEN G. ROTHROCK, MD 
University of Michigan, Ann Arbor, MI 
Section of Emergency Medicine (JGY) 
Orlando Regional Medical Center, Or- 
lando, FL 
Department of Emergency Medicine 
(JLF, SGR) 
Prior presentation: SAEMEMRS Combined 
Meeting, Cambridge, UK, September 1993. 
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The Emergency Medical 
Services Provider:Patient 
Patch Ratio 
To the Ediror:-Recently, I made an 
empirical observation that 1 believe has 
gone unreported in the emergency med- 
icine literature. 
Historically. there has been a posi- 
tive correlation between the level of 
training of an emergency medical ser- 
vices (EMS) provider with the number 
of patches worn on the provider’s uni- 
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form. Also from a historical standpoint, 
in the early days of organized EMS sys- 
tems, patients transported by EMS per- 
sonnel were rarely noted to be wearing 
any “patches” (e.g., chest electrodes). 
Given this observation, a mathematical 
representation of the ratio between the 
number of patches worn by the EMS 
personnel and the number worn by the 
patient offered a simple but accurate 
bedside means of determining the level 
of EMS care provided on a given call. 
For example, a patient receiving 
EMS basic life support (BLS) care 
would not be expected to be wearing any 
patches and the EMS provider would be 
expected to have few patches. In the 
most basic scenario, the provider would 
have 1 patch, and the patient would have 
none. Using the formula [(number of 
patches worn by EMS provider):co- 
sine(number of patches worn by pa- 
tient)], is., P,,:cosine p,, provides a 
providerpatient patch ratio (PPPR) of 
1 : 1, indicating that no advanced life sup- 
port (ALS) was provided. 
As the level of certification of the 
provider increases, with a resultant in- 
crease in the number of provider patches 
worn, the PPPR would increase to x:l. 
with x being the increased number of 
provider patches worn. For example, a 
patient with no patch and a provider with 
2 patches yields a PPPR of 2.0; a patient 
with no patch and a provider with 10 
patches would yield a PPPR of 10. 
Therefore, a higher PPPR correlates to a 
greater level of provider certification. 
and hence a higher level of EMS care. 
A PPPR 2 5 suggests that intermediate- 
level EMS care was provided and a 
PPPR 2 10 suggests that ALS care was 
provided. 
Those who are mathematically chal- 
lenged should note that the use of the 
cosine term in the equation makes this 
expression highly dependent on the 
I TABLE 1 Calculation of the Provider: 
Patient Patch Ratio (PPPR) ................................................ 
No. No. Cosine No. 
Provider Patient Patient 
Patches Patches Patches PPPR 
1 0 1 .Ooo 1 .o 
1 3 0.999 1 .o 
5 3 0.999 5.0 
10 0 1 .Ooo 10.0 
10 3 0.999 10.1 
10 8 0.990 10.1 
number of provider patches (Table 1). 
Hence, even when BLS providers begin 
using monitoring electrodes and transcu- 
taneous O2 patches in a community, the 
PPPR remains relatively unaffected. 
Clinically, one need not be con- 
cerned with the minutiae of performing 
precise measurements of the PPPR. A 
quick notation of the number of patches 
worn by the EMS provider should give 
the practitioner a sense of the degree of 
EMS care provided. 
JOSEPH c. SCIAMMARELLA JR.. MD 
Mercy Medical Center, Rockville Cen- 
tre. NY 
Key words: EMS; emergency medical ser- 
vices; level of service. 
.................................................... 
Editor’s note: 
Having defined the level of EMS care pro- 
vided using this quantitative method. fu- 
ture studies are warranted to evaluate the 
impact of numbers of patches and patch 
ratios on patient outcomes. It is likely that 
a strong association will be seen between 
both patient and provider patch counts and 
EMS charges in fee-for-service EMS sys- 
tems. I also anticipate that EMS scene time 
intervals will be increased in relationship 
to patch counts. 
